"/
Sunday, October 22, 2017

Professor Adam Jaffe - BT4K Co-Chairperson

Professor Adam Jaffé is a Paediatric Respiratory Consultant at Sydney Children’s Hospital, Associate Director of Research for Sydney Children’s Hospitals Network, Randwick and the John Beveridge Professor and Head of the Discipline of Paediatrics at the University of New South Wales. Professor Jaffé trained partly in Sydney, but mostly in London and gained his thesis in Gene Therapy for Children with Cystic Fibrosis from Imperial College, University of London.

His research career centres around translational research specifically aimed at improving child health outcomes. His research interests lie in the areas of cystic fibrosis, empyema, asthma, childhood pneumonia and rare “orphan” lung diseases.

He is chairman of the NSW Department of Health, Aiming for Asthma Improvement in Children Program and Chairman of the Orphan Lung Disease Taskforce of the Lung Foundation Australian. He is also on the medical and scientific advisory board of Asthma Australia as well as the Cystic Fibrosis Australia Data Registry Committee. Prof Jaffé established the British Paediatric Orphan Lung Disease Registry (BPOLD) and for the first time published prevalence data on rare lung diseases in the UK; crucial for the development of orphan drugs. He subsequently set up an Australasian equivalent; Australasian Registry Network for Orphan Lung Disease (ARNOLD) following his move to Australia in 2006. He also set up the Australian Research Network in Empyema (ARNiE) in 2008 which, for the first time investigated the bacterial causes of children with empyema and generated data to help inform immunisation planning for Pneumococcal disease in Australia.

Professor Jaffé has over 100 publications and has been associated with over$6 million in grant awards, including 3 current NHMRC grants as CI.

You can read more about Professor Jaffe, including a listing of his publications, here: University of New South Wales.